AARSD1-RGS9 Fusion FISH Probe
The AARSD1-RGS9 Fusion FISH Probe is used to confirm a fusion of the AARSD1 and RGS9 genes. The fusion of the AARSD1 and RGS9 genes has been associated with Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| AARSD1-RGS9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| AARSD1-RGS9-20-AQAQ | 20 (40 μL) | 200 μL |
|
RGS9 Gene Summary
This gene encodes a member of the RGS family of GTPase activating proteins that function in various signaling pathways by accelerating the deactivation of G proteins. This protein is anchored to photoreceptor membranes in retinal cells and deactivates G proteins in the rod and cone phototransduction cascades. Mutations in this gene result in bradyopsia. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Gene Name: Regulator Of G Protein Signaling 9
Chromosome: CHR17: 63133455 -63223821
Locus: 17q24.1
AARSD1 Gene Summary
The Alanyl-tRNA Synthetase Domain Containing 1 (AARSD1) gene is located on chr17 :41102542-41132545 at 17q21.31.
Gene Name: Alanyl-tRNA Synthetase Domain Containing 1
Chromosome: CHR17: 41102542 -41132545
Locus: 17q21.31
Gene Diseases
The AARSD1 RGS9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Cervical Squamous Cell Carcinoma And Endocervical Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|